Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Tatiana M. Neal"'
Autor:
Jennifer Y. Wang, Shyam S. Raghavan, Ryanne A. Brown, Youn H. Kim, Kelsey E. Hirotsu, Roberto A. Novoa, Kerri E. Rieger, Tatiana M. Neal, Michael S. Khodadoust, Bernice Y. Kwong
Publikováno v:
American Journal of Surgical Pathology. 44:1666-1676
Rash is one of the most common adverse events observed with mogamulizumab, an anti-C-C chemokine receptor 4 monoclonal antibody approved for previously treated mycosis fungoides (MF) and Sezary syndrome (SS). Given the nonspecific clinical presentati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ce64bcd9c5013e95f20b10983949898
https://doi.org/10.1097/pas.0000000000001587
https://doi.org/10.1097/pas.0000000000001587
Autor:
Youn H. Kim, Kerri E. Rieger, Jennifer Y. Wang, Kelsey E. Hirotsu, Tatiana M. Neal, Jenna Strelo, Bernice Y. Kwong, Michael S. Khodadoust, E. Hong
Publikováno v:
JAMA Dermatol
Importance Mogamulizumab is a monoclonal antibody against CCR4 approved for treatment for mycosis fungoides (MF) and Sezary syndrome (SS). Mogamulizumab-associated rash (MAR) is difficult to differentiate from cutaneous MF or SS, which can lead to un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c98273416da9952b7f438f388cbbbd17
https://pubmed.ncbi.nlm.nih.gov/33881447
https://pubmed.ncbi.nlm.nih.gov/33881447